Cervinara (IT)
{name}
{subtitle}
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~15 mi. (Napoli, Italy, +192 more cities)
facility
Istituto Nazionale Tumori IRCCS Fondazione Pascale
biomarker
ER Positive, +1 more biomarker
condition
Breast Carcinoma
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~15 mi. (Napoli, Italy, +383 more cities)
facility
Istituto Nazionale Tumori Irccs Fondazione g. PASCALE;U.O.C. Oncologia Medica Senologica
biomarker
ER Negative, +2 more biomarkers
condition
Breast Carcinoma
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~15 mi. (Napoli, Italy, +140 more cities)
facility
Ospedale del Mare ( Site 0327)
condition
Hepatocellular Carcinoma
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
city
~15 mi. (Napoli, Italy, +122 more cities)
facility
A.O.R.N. Antonio Cardarelli
condition
Prostate Adenocarcinoma
drug
radium Ra 223 dichloride
drug type
radiation therapy
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
city
~15 mi. (Napoli, Italy, +262 more cities)
facility
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale
biomarker
ER Positive, +1 more biomarker
condition
Breast Adenocarcinoma
drug
giredestrant, +2 more drugs
drug type
hormone therapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~15 mi. (Napoli, Italy, +260 more cities)
facility
Università degli Studi Federico II; Clinica di Oncologia Medica, +1 more facility
biomarker
ERBB2 Amplification, +1 more biomarker
condition
Invasive Breast Carcinoma
drug
ado-trastuzumab emtansine, +1 more drug
drug type
immunotherapy, +1 more type
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
city
~15 mi. (Napoli, Italy, +115 more cities)
facility
Istituto Nazionale Tumori Irccs Fondazione g. PASCALE;U.O.C. Oncologia Medica Senologica, +1 more facility
biomarker
ERBB2 Amplification, +7 more biomarkers
condition
Breast Carcinoma
drug
ado-trastuzumab emtansine, +1 more drug
drug type
immunotherapy, +1 more type
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
city
~15 mi. (Napoli, Italy, +81 more cities)
facility
Fondazione Pascale; U.O. Sperimentazioni Cliniche, +2 more facilities
condition
Hepatocellular Carcinoma
drug
atezolizumab, +2 more drugs
drug type
immunotherapy, +1 more type
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
city
~15 mi. (Napoli, Italy, +179 more cities)
facility
Università degli Studi della Campania Luigi Vanvitelli; Divsione Di Oncologia Medica
condition
Esophageal Squamous Cell Carcinoma
drug
atezolizumab, +1 more drug
drug type
immunotherapy